Table of contents

Original research

• Expression of cathepsins B, D and K in thymic epithelial tumours (28 May, 2020)

  Naoko Yamaguchi, Utano Tomaru, Takayuki Kiuchi, Akihiro Ishizu, Takahiro Deguchi, Noriyuki Otsuka, Satoshi Tanaka, Katsuji Marukawa, Yoshihiro Matsuno, Masanobu Kitagawa, Masanori Kasahara
• Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer (29 May, 2020)

  Tara Spence, Sheron Perera, Jessica Weiss, Sylvie Grenier, Laura Ranich, Frances Shepherd, Tracy L Stockley
• In situ hybridisation for albumin RNA in paediatric liver cancers compared with common immunohistochemical markers (29 May, 2020)

  Diane Ann Chen, Anne Koehne de Gonzalez, Ladan Fazlollahi, Amy Coffey, Helen E. Remotti, Stephen M. Lagana
• Methylation study of the Paris system for reporting urinary (TPS) categories (11 June, 2020)

  Francesco Pierconti, Maurizio Martini, Tonia Cenci, Vincenzo Fiorentino, Emilio Sacco, Riccardo Bientinesi, Dario Pugliese, Roberto Iacovelli, Giovanni Schinzari, Luigi Maria Larocca, Pier Francesco Bassi
• Non-amplification genetic alterations of HER2 gene in non-small cell lung carcinoma (11 June, 2020)

  Anurag Mehta, Shrinidhi Nathany, Rupal Tripathi, Sanjeev Kumar Sharma, Mumtaz Saifi, Ullas Batra
• Clinicopathological significance of CD47 expression in hepatocellular carcinoma (23 June, 2020)

  Hyunsung Kim, Seongsik Bang, Seungyun Jee, Seung Sam Paik, Kiseok Jang
• Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer (23 June, 2020)

  Isaac KS Ng, Nesaretnam Barr Kumarakulasinghe, Nicholas L Syn, Ross Andrew Soo
• Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation status (23 June, 2020)

  Mikaela Holmes, Annabelle Mahar, Trina Lum, Steven Kao, Wendy Anne Cooper